Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) just unveiled an update.
Concord Healthcare Group Co., Ltd. has announced an extraordinary general meeting (EGM) scheduled for December 5, 2025, to discuss the abolition of the Supervisory Committee and propose amendments to the Articles of Association and procedural rules. This move could streamline the company’s governance structure, potentially impacting its operational efficiency and stakeholder engagement.
The most recent analyst rating on (HK:2453) stock is a Sell with a HK$2.00 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the healthcare industry. The company is focused on providing healthcare services and products, with a market presence in China.
Average Trading Volume: 3,607,313
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.77B
For a thorough assessment of 2453 stock, go to TipRanks’ Stock Analysis page.

